Glenn leverages over 20 years of experience as a practicing oncologist and clinical translational researcher to guide AIQ’s clinical strategy and the development of technologies that improve clinical decision making through better understanding of treatment response.

An internationally recognized leader in drug development and genitourinary oncology, Dr. Liu is a tenured Professor of Medicine and Medical Physics at the University of Wisconsin–Madison and serves as Leader of Genitourinary Oncology and Director of Genitourinary Research at the University of Wisconsin Carbone Cancer Center.

He also plays a national role in advancing new cancer therapies and biomarker development as a member of the National Cancer Institute Investigational Drug Steering Committee Prostate Cancer Clinical Trials Consortium, and Experimental Therapeutics Clinical Trials Network.

Dr. Liu received his M.D. from Jefferson Medical College in Philadelphia and completed his residency in Internal Medicine and fellowship in Medical Oncology at the University of Wisconsin.